Search

Home > JAMA Network > JAMA Oncology : Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
Podcast: JAMA Network
Episode:

JAMA Oncology : Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
Category: Science & Medicine
Duration: 00:12:11
Publish Date: 2018-07-05 10:00:00
Description:

Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
Total Play: 0